For CD33, the precise physiological functions have remained unclear, but recently, genome-wide association studies have identified variants of CD33 as a major risk factor for Alzheimer's disease, suggesting an important role in neurodegeneration [2]. The gene discussed is CD33; the disease is early-onset autosomal dominant Alzheimer disease.